Fruquintinib (Elunate)
Revision as of 17:45, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Investigational" to "Category:Investigational drugs")
Mechanism of action
VEGFR inhibitor
Preliminary data
Colon cancer
- FRESCO: Li J, Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Fan S, Hua Y, Su W. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial. JAMA. 2018 Jun 26;319(24):2486-2496. link to original article PubMed
Also known as
- Code name: HMPL-013